| Puberty |
0 |
0.99 |
| Precocious Puberty |
0 |
1 |
| Pain Management |
0 |
0.48 |
| Bone |
0 |
0.38 |
| Tumor |
0 |
0.33 |
| Pubic |
0 |
0.31 |
| McCune-Albright Syndrome |
0 |
0.3 |
| Leydig Cell Tumor |
0 |
0.29 |
| Adrenal Tumor |
0 |
0.27 |
| Germ Cell Tumor |
0 |
0.27 |
| Abdominal Pain |
0 |
0.25 |
| Pituitary Tumor |
0 |
0.25 |
| Child |
0 |
0.24 |
| Obesity |
0 |
0.24 |
| Genomic Medicine |
0 |
0.22 |
| Breast |
0 |
0.21 |
| Headache |
0 |
0.18 |
| Infertility Female |
0 |
0.18 |
| Ovarian Cyst |
0 |
0.16 |
| Pituitary Gland |
0 |
0.15 |
| Thyroid Disease |
0 |
0.15 |
| Abdomen |
0 |
0.14 |
| Genetics |
0 |
0.14 |
| Pain |
0 |
0.14 |
| Seizure |
0 |
0.14 |
| Testosterone |
0 |
0.14 |
| Adrenal Gland |
0 |
0.13 |
| Central Nervous System |
0 |
0.1 |
| Florida |
0 |
0.1 |
| Gland |
0 |
0.1 |
| Hair |
0 |
0.1 |
| In Vitro Fertilization |
0 |
0.1 |
| Ovary |
0 |
0.1 |
| Polycystic Ovary Syndrome |
0 |
0.1 |
| Psychosocial |
0 |
0.1 |
| Steroids |
0 |
0.1 |
| Virilization |
0 |
0.1 |
| Fibrous Dysplasia |
0 |
0.07 |
| Pelvic Ultrasonography |
0 |
0.07 |
| Selective Estrogen Receptor Modulators |
0 |
0.07 |
| Sexual Abuse |
0 |
0.07 |
| Acromegaly |
0 |
0.06 |
| Cushing Syndrome |
0 |
0.06 |
| Hyperthyroidism |
0 |
0.06 |
| Hypothyroidism |
0 |
0.06 |
| Abuse |
0 |
0.05 |
| Body Mass Index |
0 |
0.05 |
| Brain |
0 |
0.05 |
| Bromhidrosis |
0 |
0.05 |
| Cancer |
0 |
0.05 |
| Congenital Adrenal Hyperplasia |
0 |
0.05 |
| Dysplasia |
0 |
0.05 |
| Endocrinology |
0 |
0.05 |
| Estrogen |
0 |
0.05 |
| Fertility |
0 |
0.05 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.05 |
| Growth Hormone |
0 |
0.05 |
| Hamartoma |
0 |
0.05 |
| Nutrition |
0 |
0.05 |
| Patient History |
0 |
0.05 |
| Pigmentation |
0 |
0.05 |
| Skeletal |
0 |
0.05 |
| Thyrotoxicosis |
0 |
0.05 |
| Tissue |
0 |
0.05 |
| Ultrasonography |
0 |
0.05 |
| Uterus |
0 |
0.05 |